Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of April 2025. The report specifically details a transaction in the company's own shares conducted under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity and capital structure updates.
- Shares Purchased: 838,848 ordinary shares
- Purchase Date: April 24, 2025
- Highest Price Paid: 380.70 pence per share
- Lowest Price Paid: 375.20 pence per share
- Volume Weighted Average Price: 377.33 pence per share
- Registered Share Capital: 9,024,461,272 ordinary shares of £0.01 each
- Treasury Shares: 4,080,205
- Voting Shares: 9,020,381,067
Material Changes
Following the settlement of the April 24 transaction, the company's registered share capital and the number of shares held as treasury shares have been updated. The number of ordinary shares with voting rights is now 9,020,381,067, a figure shareholders must use for notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation of an offer for securities. A full breakdown of individual trades is available via the London Stock Exchange link provided in the filing.
Key Facts for Investor Verification
- Verify the total number of shares repurchased to date under the March 28, 2025 Buyback Programme.
- Confirm the current number of treasury shares held (4,080,205) against the latest capital structure.
- Review the full trade breakdown at the provided RNS link for detailed execution data.
- Check the updated voting share count (9,020,381,067) for compliance with disclosure thresholds.